{"truths": ["Simvastatin", "Sildenafil", "Furosemide", "Etoricoxib"], "actions": ["In vitro enzyme inhibition assay", "Pharmacokinetics profiling", "Bioavailability study", "Solubility test", "High-throughput screening assay", "Off-target activity screening"], "observations": {"In vitro enzyme inhibition assay": 2257.71206470011, "Pharmacokinetics profiling": "Short half-life", "Bioavailability study": 81.89661526953712, "Solubility test": "Poorly soluble", "High-throughput screening assay": "Active", "Off-target activity screening": "Low off-target activity"}, "seed": 0, "valid_truth": "Etoricoxib"}
{"truths": ["Fluoxetine", "Ibuprofen", "Codeine", "Atorvastatin"], "actions": ["Cytokine release assay", "Therapeutic index calculation", "Bioavailability study", "Cell viability assay", "Lipophilicity measurement (LogP)", "Human clinical trial Phase I"], "observations": {"Cytokine release assay": "High cytokine release", "Therapeutic index calculation": 539.0709908717329, "Bioavailability study": 97.8663408511527, "Cell viability assay": 69.4904403510567, "Lipophilicity measurement (LogP)": -1.9628100185736983, "Human clinical trial Phase I": "Severe adverse effects"}, "seed": 1, "valid_truth": "Fluoxetine"}
{"truths": ["Tadalafil", "Sodium lauryl sulfate", "Cetirizine", "Azithromycin"], "actions": ["hERG channel inhibition assay", "Ames mutagenicity test", "Off-target activity screening", "High-throughput screening assay", "QT prolongation assessment", "Eye irritation test"], "observations": {"hERG channel inhibition assay": 99.98593979726346, "Ames mutagenicity test": "Negative", "Off-target activity screening": "High off-target activity", "High-throughput screening assay": "Active", "QT prolongation assessment": "Prolongs QT", "Eye irritation test": "Non-irritant"}, "seed": 2, "valid_truth": "Sodium lauryl sulfate"}
{"truths": ["Interferon", "Formaldehyde", "Phenytoin", "Aspirin"], "actions": ["Dose-response study", "Immunogenicity testing", "Eye irritation test", "Human clinical trial Phase I", "Micronucleus test", "Animal toxicity test"], "observations": {"Dose-response study": "Linear response", "Immunogenicity testing": "Immunogenic", "Eye irritation test": "Irritant", "Human clinical trial Phase I": "Severe adverse effects", "Micronucleus test": "Negative", "Animal toxicity test": "Low toxicity"}, "seed": 3, "valid_truth": "Aspirin"}
{"truths": ["Interferon", "Amphotericin B", "Atenolol", "Valproic Acid"], "actions": ["Human clinical trial Phase I", "Immunogenicity testing", "Renal function test", "Teratogenicity assessment", "CYP450 metabolism assay", "Animal toxicity test"], "observations": {"Human clinical trial Phase I": "Severe adverse effects", "Immunogenicity testing": "Immunogenic", "Renal function test": "Nephrotoxic", "Teratogenicity assessment": "Non-teratogenic", "CYP450 metabolism assay": "Weak inhibitor", "Animal toxicity test": "Low toxicity"}, "seed": 4, "valid_truth": "Valproic Acid"}
{"truths": ["Amiodarone", "Tamoxifen", "Amoxicillin", "Neomycin sulfate"], "actions": ["Genotoxicity assay", "Drug-drug interaction studies", "Skin sensitization test", "Renal function test", "Carcinogenicity study", "Pharmacokinetics profiling"], "observations": {"Genotoxicity assay": "Genotoxic", "Drug-drug interaction studies": "Significant interaction", "Skin sensitization test": "Sensitizer", "Renal function test": "Nephrotoxic", "Carcinogenicity study": "Carcinogenic", "Pharmacokinetics profiling": "Long half-life"}, "seed": 5, "valid_truth": "Amoxicillin"}
{"truths": ["Nifedipine", "Cetirizine", "Acyclovir", "Etoricoxib"], "actions": ["Animal toxicity test", "Receptor binding affinity assay", "Ames mutagenicity test", "Solubility test", "P-glycoprotein interaction assay", "hERG channel inhibition assay"], "observations": {"Animal toxicity test": "High toxicity", "Receptor binding affinity assay": 38.506991796899506, "Ames mutagenicity test": "Positive", "Solubility test": "Moderately soluble", "P-glycoprotein interaction assay": "Inhibitor", "hERG channel inhibition assay": 20.90792342687883}, "seed": 6, "valid_truth": "Nifedipine"}
{"truths": ["Loperamide", "Ciprofloxacin", "Valproic Acid", "Tamoxifen"], "actions": ["Dose-response study", "Genotoxicity assay", "Teratogenicity assessment", "Carcinogenicity study", "Ames mutagenicity test", "P-glycoprotein interaction assay"], "observations": {"Dose-response study": "Linear response", "Genotoxicity assay": "Genotoxic", "Teratogenicity assessment": "Teratogenic", "Carcinogenicity study": "Carcinogenic", "Ames mutagenicity test": "Positive", "P-glycoprotein interaction assay": "Inhibitor"}, "seed": 7, "valid_truth": "Loperamide"}
{"truths": ["Prednisone", "Aspirin", "Estradiol", "Phenytoin"], "actions": ["Dose-response study", "Genotoxicity assay", "Carcinogenicity study", "CYP450 metabolism assay", "Animal toxicity test", "Oxidative stress assay"], "observations": {"Dose-response study": "Linear response", "Genotoxicity assay": "Genotoxic", "Carcinogenicity study": "Carcinogenic", "CYP450 metabolism assay": "Strong inhibitor", "Animal toxicity test": "Moderate toxicity", "Oxidative stress assay": "Induces ROS"}, "seed": 8, "valid_truth": "Aspirin"}
{"truths": ["Zolpidem", "Aspirin", "Gabapentin", "Fluoxetine"], "actions": ["Blood-brain barrier permeability test", "Animal behavioral study", "Human clinical trial Phase I", "CYP450 metabolism assay", "Cardiac function test", "Mitochondrial toxicity test"], "observations": {"Blood-brain barrier permeability test": "Does not penetrate BBB", "Animal behavioral study": "No behavioral changes", "Human clinical trial Phase I": "No adverse effects", "CYP450 metabolism assay": "Strong inhibitor", "Cardiac function test": "Cardiotoxic", "Mitochondrial toxicity test": "No mitochondrial toxicity"}, "seed": 9, "valid_truth": "Aspirin"}
{"truths": ["Nifedipine", "Cisplatin", "Lamivudine", "Albuterol"], "actions": ["In vitro enzyme inhibition assay", "Ames mutagenicity test", "Oxidative stress assay", "Reactive oxygen species (ROS) assay", "P-glycoprotein interaction assay", "hERG channel inhibition assay"], "observations": {"In vitro enzyme inhibition assay": 52.06693596399246, "Ames mutagenicity test": "Positive", "Oxidative stress assay": "Induces ROS", "Reactive oxygen species (ROS) assay": "Low ROS generation", "P-glycoprotein interaction assay": "Substrate", "hERG channel inhibition assay": 3.2777281162209313}, "seed": 10, "valid_truth": "Nifedipine"}
{"truths": ["Digoxin", "Clarithromycin", "Zolpidem", "Metoprolol"], "actions": ["Human clinical trial Phase I", "Blood-brain barrier permeability test", "P-glycoprotein interaction assay", "CYP450 metabolism assay", "Therapeutic index calculation", "Animal behavioral study"], "observations": {"Human clinical trial Phase I": "Severe adverse effects", "Blood-brain barrier permeability test": "Does not penetrate BBB", "P-glycoprotein interaction assay": "Substrate", "CYP450 metabolism assay": "Weak inhibitor", "Therapeutic index calculation": 1.4179512925945614, "Animal behavioral study": "No behavioral changes"}, "seed": 11, "valid_truth": "Clarithromycin"}
{"truths": ["Doxycycline", "Gabapentin", "Terfenadine", "Omeprazole"], "actions": ["In vitro enzyme inhibition assay", "hERG channel inhibition assay", "Ames mutagenicity test", "Dose-response study", "CYP450 metabolism assay", "Blood-brain barrier permeability test"], "observations": {"In vitro enzyme inhibition assay": 7215.333877348161, "hERG channel inhibition assay": 6.014570387277331, "Ames mutagenicity test": "Positive", "Dose-response study": "Sigmoidal response", "CYP450 metabolism assay": "Weak inhibitor", "Blood-brain barrier permeability test": "Penetrates BBB"}, "seed": 12, "valid_truth": "Gabapentin"}
{"truths": ["Etoricoxib", "Sodium Valproate", "Morphine", "Prednisone"], "actions": ["In vitro enzyme inhibition assay", "Animal toxicity test", "Carcinogenicity study", "Cytokine release assay", "Mitochondrial toxicity test", "Solubility test"], "observations": {"In vitro enzyme inhibition assay": 29.465675376336254, "Animal toxicity test": "High toxicity", "Carcinogenicity study": "Carcinogenic", "Cytokine release assay": "High cytokine release", "Mitochondrial toxicity test": "No mitochondrial toxicity", "Solubility test": "Moderately soluble"}, "seed": 13, "valid_truth": "Sodium Valproate"}
{"truths": ["Atenolol", "Terfenadine", "Amiodarone", "Gabapentin"], "actions": ["Human clinical trial Phase I", "Dose-response study", "hERG channel inhibition assay", "QT prolongation assessment", "Blood-brain barrier permeability test", "Drug-drug interaction studies"], "observations": {"Human clinical trial Phase I": "Severe adverse effects", "Dose-response study": "Non-linear response", "hERG channel inhibition assay": 3.9380962235865424, "QT prolongation assessment": "No effect on QT", "Blood-brain barrier permeability test": "Does not penetrate BBB", "Drug-drug interaction studies": "No significant interaction"}, "seed": 14, "valid_truth": "Amiodarone"}
{"truths": ["Montelukast", "Imatinib", "Saline solution", "Cisplatin"], "actions": ["In vitro enzyme inhibition assay", "Oxidative stress assay", "Eye irritation test", "Reactive oxygen species (ROS) assay", "Clinical biomarker identification", "Glutathione depletion assay"], "observations": {"In vitro enzyme inhibition assay": 11.712983502505537, "Oxidative stress assay": "Induces ROS", "Eye irritation test": "Non-irritant", "Reactive oxygen species (ROS) assay": "High ROS generation", "Clinical biomarker identification": "Biomarker identified", "Glutathione depletion assay": "Depletes glutathione"}, "seed": 15, "valid_truth": "Imatinib"}
{"truths": ["Azithromycin", "Doxycycline", "Albuterol", "Sertraline"], "actions": ["In vitro enzyme inhibition assay", "Ames mutagenicity test", "Solubility test", "QT prolongation assessment", "Animal behavioral study", "Receptor binding affinity assay"], "observations": {"In vitro enzyme inhibition assay": 63.49959241034841, "Ames mutagenicity test": "Positive", "Solubility test": "Highly soluble", "QT prolongation assessment": "No effect on QT", "Animal behavioral study": "Behavioral changes observed", "Receptor binding affinity assay": 0.5064186813672489}, "seed": 16, "valid_truth": "Sertraline"}
{"truths": ["Saline solution", "Sildenafil", "Amphotericin B", "Azithromycin"], "actions": ["In vitro enzyme inhibition assay", "Ames mutagenicity test", "Eye irritation test", "QT prolongation assessment", "Solubility test", "Off-target activity screening"], "observations": {"In vitro enzyme inhibition assay": 8336.674799900924, "Ames mutagenicity test": "Negative", "Eye irritation test": "Non-irritant", "QT prolongation assessment": "Prolongs QT", "Solubility test": "Highly soluble", "Off-target activity screening": "Low off-target activity"}, "seed": 17, "valid_truth": "Amphotericin B"}
{"truths": ["Morphine", "Acetaminophen", "Digoxin", "Losartan"], "actions": ["Metabolic stability assay", "P-glycoprotein interaction assay", "Cytokine release assay", "Blood-brain barrier permeability test", "Skin sensitization test", "Pharmacodynamics evaluation"], "observations": {"Metabolic stability assay": "Unstable", "P-glycoprotein interaction assay": "Substrate", "Cytokine release assay": "High cytokine release", "Blood-brain barrier permeability test": "Penetrates BBB", "Skin sensitization test": "Sensitizer", "Pharmacodynamics evaluation": "Unexpected effect"}, "seed": 18, "valid_truth": "Acetaminophen"}
{"truths": ["Furosemide", "Saline solution", "Acetaminophen", "Metoprolol"], "actions": ["Human clinical trial Phase I", "Pharmacokinetics profiling", "Skin sensitization test", "Eye irritation test", "Therapeutic index calculation", "Metabolic stability assay"], "observations": {"Human clinical trial Phase I": "Severe adverse effects", "Pharmacokinetics profiling": "Short half-life", "Skin sensitization test": "Non-sensitizer", "Eye irritation test": "Irritant", "Therapeutic index calculation": 635.4996385795675, "Metabolic stability assay": "Stable"}, "seed": 19, "valid_truth": "Saline solution"}
{"truths": ["Cisapride", "Erythromycin", "Ketoconazole", "Atenolol"], "actions": ["Human clinical trial Phase I", "hERG channel inhibition assay", "P-glycoprotein interaction assay", "QT prolongation assessment", "Drug-drug interaction studies", "CYP450 metabolism assay"], "observations": {"Human clinical trial Phase I": "Severe adverse effects", "hERG channel inhibition assay": 3.1690398324559297, "P-glycoprotein interaction assay": "Inhibitor", "QT prolongation assessment": "No effect on QT", "Drug-drug interaction studies": "Significant interaction", "CYP450 metabolism assay": "Strong inhibitor"}, "seed": 20, "valid_truth": "Erythromycin"}
{"truths": ["Insulin", "Sildenafil", "Sertraline", "Albuterol"], "actions": ["In vitro enzyme inhibition assay", "Immunogenicity testing", "Animal behavioral study", "Bioavailability study", "Knockout mouse model efficacy study", "Receptor binding affinity assay"], "observations": {"In vitro enzyme inhibition assay": 1.4121348940183798, "Immunogenicity testing": "Immunogenic", "Animal behavioral study": "No behavioral changes", "Bioavailability study": 98.65556263705528, "Knockout mouse model efficacy study": "Effective", "Receptor binding affinity assay": 21.409555922919793}, "seed": 21, "valid_truth": "Sildenafil"}
{"truths": ["Fluoxetine", "Amiodarone", "Cisapride", "Digoxin"], "actions": ["hERG channel inhibition assay", "P-glycoprotein interaction assay", "Animal behavioral study", "Drug-drug interaction studies", "Therapeutic index calculation", "QT prolongation assessment"], "observations": {"hERG channel inhibition assay": 9.594850618366994, "P-glycoprotein interaction assay": "Substrate", "Animal behavioral study": "No behavioral changes", "Drug-drug interaction studies": "No significant interaction", "Therapeutic index calculation": 3.194518385537368, "QT prolongation assessment": "No effect on QT"}, "seed": 22, "valid_truth": "Amiodarone"}
{"truths": ["Sodium Valproate", "Cetirizine", "Loratadine", "Metformin"], "actions": ["hERG channel inhibition assay", "Mitochondrial toxicity test", "Cell viability assay", "Animal behavioral study", "Solubility test", "Blood-brain barrier permeability test"], "observations": {"hERG channel inhibition assay": 61.05195865786096, "Mitochondrial toxicity test": "Mitochondrial toxic", "Cell viability assay": 72.75164794238583, "Animal behavioral study": "No behavioral changes", "Solubility test": "Moderately soluble", "Blood-brain barrier permeability test": "Does not penetrate BBB"}, "seed": 23, "valid_truth": "Metformin"}
{"truths": ["Simvastatin", "Morphine", "Artificial tears", "Insulin"], "actions": ["In vitro enzyme inhibition assay", "Immunogenicity testing", "Eye irritation test", "Bioavailability study", "Knockout mouse model efficacy study", "Cytokine release assay"], "observations": {"In vitro enzyme inhibition assay": 7520.043956485525, "Immunogenicity testing": "Immunogenic", "Eye irritation test": "Non-irritant", "Bioavailability study": 95.31885564516658, "Knockout mouse model efficacy study": "Effective", "Cytokine release assay": "Low cytokine release"}, "seed": 24, "valid_truth": "Morphine"}
{"truths": ["Estradiol", "Imatinib", "Artificial tears", "Metformin"], "actions": ["Genotoxicity assay", "Clinical biomarker identification", "Eye irritation test", "CYP450 metabolism assay", "Metabolic stability assay", "Lipophilicity measurement (LogP)"], "observations": {"Genotoxicity assay": "Genotoxic", "Clinical biomarker identification": "No biomarker identified", "Eye irritation test": "Non-irritant", "CYP450 metabolism assay": "No inhibition", "Metabolic stability assay": "Unstable", "Lipophilicity measurement (LogP)": -2.0574299298737024}, "seed": 25, "valid_truth": "Metformin"}
{"truths": ["Warfarin", "Montelukast", "Placebo", "Formaldehyde"], "actions": ["In vitro enzyme inhibition assay", "Human clinical trial Phase I", "Eye irritation test", "Animal toxicity test", "Receptor binding affinity assay", "Teratogenicity assessment"], "observations": {"In vitro enzyme inhibition assay": 98.67575298826218, "Human clinical trial Phase I": "No adverse effects", "Eye irritation test": "Irritant", "Animal toxicity test": "High toxicity", "Receptor binding affinity assay": 234.11330001614604, "Teratogenicity assessment": "Non-teratogenic"}, "seed": 26, "valid_truth": "Warfarin"}
{"truths": ["Albuterol", "Penicillin", "Sertraline", "Warfarin"], "actions": ["Drug-drug interaction studies", "Animal behavioral study", "Bioavailability study", "Teratogenicity assessment", "Receptor binding affinity assay", "Renal function test"], "observations": {"Drug-drug interaction studies": "Significant interaction", "Animal behavioral study": "No behavioral changes", "Bioavailability study": 16.683036508391172, "Teratogenicity assessment": "Non-teratogenic", "Receptor binding affinity assay": 4327.566178453567, "Renal function test": "Non-nephrotoxic"}, "seed": 27, "valid_truth": "Albuterol"}
{"truths": ["Neomycin sulfate", "Phenytoin", "Formaldehyde", "Clopidogrel"], "actions": ["Animal toxicity test", "Skin sensitization test", "Eye irritation test", "Pharmacogenomics analysis", "Human clinical trial Phase I", "Dose-response study"], "observations": {"Animal toxicity test": "Moderate toxicity", "Skin sensitization test": "Sensitizer", "Eye irritation test": "Irritant", "Pharmacogenomics analysis": "No genetic impact", "Human clinical trial Phase I": "Severe adverse effects", "Dose-response study": "Non-linear response"}, "seed": 28, "valid_truth": "Phenytoin"}
{"truths": ["Lisinopril", "Ketoconazole", "Omeprazole", "Sertraline"], "actions": ["CYP450 metabolism assay", "P-glycoprotein interaction assay", "Animal behavioral study", "Drug-drug interaction studies", "Cardiac function test", "Blood-brain barrier permeability test"], "observations": {"CYP450 metabolism assay": "Strong inhibitor", "P-glycoprotein interaction assay": "Inhibitor", "Animal behavioral study": "No behavioral changes", "Drug-drug interaction studies": "No significant interaction", "Cardiac function test": "Cardiotoxic", "Blood-brain barrier permeability test": "Does not penetrate BBB"}, "seed": 29, "valid_truth": "Lisinopril"}
{"truths": ["Formaldehyde", "Sodium Valproate", "Cisapride", "Montelukast"], "actions": ["In vitro enzyme inhibition assay", "Mitochondrial toxicity test", "Eye irritation test", "QT prolongation assessment", "hERG channel inhibition assay", "Ames mutagenicity test"], "observations": {"In vitro enzyme inhibition assay": 0.7606677662469474, "Mitochondrial toxicity test": "Mitochondrial toxic", "Eye irritation test": "Irritant", "QT prolongation assessment": "Prolongs QT", "hERG channel inhibition assay": 30.89434832113146, "Ames mutagenicity test": "Negative"}, "seed": 30, "valid_truth": "Cisapride"}
{"truths": ["Imatinib", "Doxycycline", "Neomycin sulfate", "Valproic Acid"], "actions": ["Teratogenicity assessment", "Clinical biomarker identification", "Skin sensitization test", "Ames mutagenicity test", "Blood-brain barrier permeability test", "High-throughput screening assay"], "observations": {"Teratogenicity assessment": "Teratogenic", "Clinical biomarker identification": "No biomarker identified", "Skin sensitization test": "Sensitizer", "Ames mutagenicity test": "Negative", "Blood-brain barrier permeability test": "Penetrates BBB", "High-throughput screening assay": "Active"}, "seed": 31, "valid_truth": "Doxycycline"}
{"truths": ["Ketoconazole", "Artificial tears", "Paracetamol", "Amphotericin B"], "actions": ["P-glycoprotein interaction assay", "Oxidative stress assay", "Renal function test", "Glutathione depletion assay", "CYP450 metabolism assay", "Human clinical trial Phase I"], "observations": {"P-glycoprotein interaction assay": "Inhibitor", "Oxidative stress assay": "Does not induce ROS", "Renal function test": "Nephrotoxic", "Glutathione depletion assay": "Depletes glutathione", "CYP450 metabolism assay": "Strong inhibitor", "Human clinical trial Phase I": "Mild adverse effects"}, "seed": 32, "valid_truth": "Artificial tears"}
{"truths": ["Nifedipine", "Insulin", "Prednisone", "Penicillin"], "actions": ["Carcinogenicity study", "P-glycoprotein interaction assay", "Immunogenicity testing", "Knockout mouse model efficacy study", "Bioavailability study", "Renal function test"], "observations": {"Carcinogenicity study": "Carcinogenic", "P-glycoprotein interaction assay": "No interaction", "Immunogenicity testing": "Immunogenic", "Knockout mouse model efficacy study": "Ineffective", "Bioavailability study": 98.87122313274713, "Renal function test": "Nephrotoxic"}, "seed": 33, "valid_truth": "Penicillin"}
{"truths": ["Simvastatin", "Azithromycin", "Codeine", "Lamivudine"], "actions": ["In vitro enzyme inhibition assay", "Ames mutagenicity test", "Solubility test", "Bioavailability study", "Cytokine release assay", "Lipophilicity measurement (LogP)"], "observations": {"In vitro enzyme inhibition assay": 3468.0660972272867, "Ames mutagenicity test": "Positive", "Solubility test": "Highly soluble", "Bioavailability study": 92.21170693657818, "Cytokine release assay": "Low cytokine release", "Lipophilicity measurement (LogP)": -1.118112684974399}, "seed": 34, "valid_truth": "Codeine"}
{"truths": ["Lisinopril", "Losartan", "Phenytoin", "Cyclosporine"], "actions": ["Dose-response study", "Cardiac function test", "Renal function test", "Metabolic stability assay", "Pharmacodynamics evaluation", "Blood-brain barrier permeability test"], "observations": {"Dose-response study": "Linear response", "Cardiac function test": "Non-cardiotoxic", "Renal function test": "Nephrotoxic", "Metabolic stability assay": "Stable", "Pharmacodynamics evaluation": "Expected effect", "Blood-brain barrier permeability test": "Does not penetrate BBB"}, "seed": 35, "valid_truth": "Losartan"}
{"truths": ["Losartan", "Tadalafil", "Loratadine", "Sertraline"], "actions": ["Receptor binding affinity assay", "Off-target activity screening", "Animal behavioral study", "In vitro enzyme inhibition assay", "Pharmacodynamics evaluation", "Blood-brain barrier permeability test"], "observations": {"Receptor binding affinity assay": 18.225687578353345, "Off-target activity screening": "High off-target activity", "Animal behavioral study": "No behavioral changes", "In vitro enzyme inhibition assay": 26.808724211733836, "Pharmacodynamics evaluation": "Expected effect", "Blood-brain barrier permeability test": "Does not penetrate BBB"}, "seed": 36, "valid_truth": "Losartan"}
{"truths": ["Sodium lauryl sulfate", "Metoprolol", "Cisplatin", "Aspirin"], "actions": ["Human clinical trial Phase I", "Oxidative stress assay", "Eye irritation test", "Micronucleus test", "Animal toxicity test", "Mitochondrial toxicity test"], "observations": {"Human clinical trial Phase I": "Severe adverse effects", "Oxidative stress assay": "Induces ROS", "Eye irritation test": "Irritant", "Micronucleus test": "Negative", "Animal toxicity test": "Low toxicity", "Mitochondrial toxicity test": "No mitochondrial toxicity"}, "seed": 37, "valid_truth": "Aspirin"}
{"truths": ["Sildenafil", "Lamivudine", "Atenolol", "Codeine"], "actions": ["In vitro enzyme inhibition assay", "Ames mutagenicity test", "Off-target activity screening", "High-throughput screening assay", "Pharmacogenomics analysis", "Cytokine release assay"], "observations": {"In vitro enzyme inhibition assay": 26.69633158304182, "Ames mutagenicity test": "Positive", "Off-target activity screening": "High off-target activity", "High-throughput screening assay": "Active", "Pharmacogenomics analysis": "No genetic impact", "Cytokine release assay": "Low cytokine release"}, "seed": 38, "valid_truth": "Atenolol"}
{"truths": ["Montelukast", "Etoricoxib", "Simvastatin", "Cisapride"], "actions": ["In vitro enzyme inhibition assay", "hERG channel inhibition assay", "Lipophilicity measurement (LogP)", "QT prolongation assessment", "Bioavailability study", "Animal toxicity test"], "observations": {"In vitro enzyme inhibition assay": 71.03923423461468, "hERG channel inhibition assay": 9.588964865706114, "Lipophilicity measurement (LogP)": -4.8644577229766295, "QT prolongation assessment": "No effect on QT", "Bioavailability study": 93.49589241784409, "Animal toxicity test": "Low toxicity"}, "seed": 39, "valid_truth": "Etoricoxib"}
{"truths": ["Trastuzumab", "Terfenadine", "Cisplatin", "Amiodarone"], "actions": ["hERG channel inhibition assay", "Drug-drug interaction studies", "Clinical biomarker identification", "QT prolongation assessment", "Oxidative stress assay", "Reactive oxygen species (ROS) assay"], "observations": {"hERG channel inhibition assay": 8.188743593441846, "Drug-drug interaction studies": "Significant interaction", "Clinical biomarker identification": "No biomarker identified", "QT prolongation assessment": "No effect on QT", "Oxidative stress assay": "Does not induce ROS", "Reactive oxygen species (ROS) assay": "Low ROS generation"}, "seed": 40, "valid_truth": "Cisplatin"}
{"truths": ["Estradiol", "Losartan", "Prednisone", "Insulin"], "actions": ["In vitro enzyme inhibition assay", "Genotoxicity assay", "Carcinogenicity study", "Bioavailability study", "Animal behavioral study", "Immunogenicity testing"], "observations": {"In vitro enzyme inhibition assay": 8030.886107993402, "Genotoxicity assay": "Genotoxic", "Carcinogenicity study": "Carcinogenic", "Bioavailability study": 93.23161944714843, "Animal behavioral study": "No behavioral changes", "Immunogenicity testing": "Non-immunogenic"}, "seed": 41, "valid_truth": "Insulin"}
{"truths": ["Neomycin sulfate", "Cisapride", "Penicillin", "Amiodarone"], "actions": ["Immunogenicity testing", "Drug-drug interaction studies", "Skin sensitization test", "Bioavailability study", "hERG channel inhibition assay", "QT prolongation assessment"], "observations": {"Immunogenicity testing": "Non-immunogenic", "Drug-drug interaction studies": "Significant interaction", "Skin sensitization test": "Sensitizer", "Bioavailability study": 80.63565358963567, "hERG channel inhibition assay": 13.747809594463698, "QT prolongation assessment": "Prolongs QT"}, "seed": 42, "valid_truth": "Cisapride"}
{"truths": ["Cisplatin", "Sertraline", "Paracetamol", "Zolpidem"], "actions": ["Blood-brain barrier permeability test", "Oxidative stress assay", "Animal behavioral study", "Glutathione depletion assay", "Animal toxicity test", "Micronucleus test"], "observations": {"Blood-brain barrier permeability test": "Does not penetrate BBB", "Oxidative stress assay": "Induces ROS", "Animal behavioral study": "No behavioral changes", "Glutathione depletion assay": "Does not deplete glutathione", "Animal toxicity test": "Moderate toxicity", "Micronucleus test": "Negative"}, "seed": 43, "valid_truth": "Paracetamol"}
{"truths": ["Erythromycin", "Saline solution", "Formaldehyde", "Neomycin sulfate"], "actions": ["CYP450 metabolism assay", "Skin sensitization test", "Eye irritation test", "QT prolongation assessment", "Metabolic stability assay", "Animal toxicity test"], "observations": {"CYP450 metabolism assay": "No inhibition", "Skin sensitization test": "Sensitizer", "Eye irritation test": "Irritant", "QT prolongation assessment": "Prolongs QT", "Metabolic stability assay": "Stable", "Animal toxicity test": "High toxicity"}, "seed": 44, "valid_truth": "Saline solution"}
{"truths": ["Gabapentin", "Sildenafil", "Acyclovir", "Atorvastatin"], "actions": ["Ames mutagenicity test", "Solubility test", "Off-target activity screening", "Dose-response study", "High-throughput screening assay", "In vitro enzyme inhibition assay"], "observations": {"Ames mutagenicity test": "Positive", "Solubility test": "Poorly soluble", "Off-target activity screening": "High off-target activity", "Dose-response study": "Linear response", "High-throughput screening assay": "Inactive", "In vitro enzyme inhibition assay": 11.48381775904468}, "seed": 45, "valid_truth": "Gabapentin"}
{"truths": ["Ketoconazole", "Isotretinoin", "Furosemide", "Prednisone"], "actions": ["CYP450 metabolism assay", "Pharmacokinetics profiling", "Carcinogenicity study", "P-glycoprotein interaction assay", "Teratogenicity assessment", "Drug-drug interaction studies"], "observations": {"CYP450 metabolism assay": "No inhibition", "Pharmacokinetics profiling": "Short half-life", "Carcinogenicity study": "Carcinogenic", "P-glycoprotein interaction assay": "Substrate", "Teratogenicity assessment": "Teratogenic", "Drug-drug interaction studies": "Significant interaction"}, "seed": 46, "valid_truth": "Isotretinoin"}
{"truths": ["Verapamil", "Codeine", "Placebo", "Lisinopril"], "actions": ["In vitro enzyme inhibition assay", "Human clinical trial Phase I", "P-glycoprotein interaction assay", "Pharmacogenomics analysis", "Cytokine release assay", "Cardiac function test"], "observations": {"In vitro enzyme inhibition assay": 79.50827212522373, "Human clinical trial Phase I": "No adverse effects", "P-glycoprotein interaction assay": "Inhibitor", "Pharmacogenomics analysis": "No genetic impact", "Cytokine release assay": "Low cytokine release", "Cardiac function test": "Cardiotoxic"}, "seed": 47, "valid_truth": "Lisinopril"}
{"truths": ["Lisinopril", "Diltiazem", "Phenytoin", "Clarithromycin"], "actions": ["In vitro enzyme inhibition assay", "CYP450 metabolism assay", "P-glycoprotein interaction assay", "Cardiac function test", "Metabolic stability assay", "Dose-response study"], "observations": {"In vitro enzyme inhibition assay": 5437.7227041412, "CYP450 metabolism assay": "Strong inhibitor", "P-glycoprotein interaction assay": "No interaction", "Cardiac function test": "Cardiotoxic", "Metabolic stability assay": "Stable", "Dose-response study": "Non-linear response"}, "seed": 48, "valid_truth": "Phenytoin"}
{"truths": ["Codeine", "Omeprazole", "Erythromycin", "Neomycin sulfate"], "actions": ["In vitro enzyme inhibition assay", "CYP450 metabolism assay", "Skin sensitization test", "Pharmacogenomics analysis", "Cytokine release assay", "QT prolongation assessment"], "observations": {"In vitro enzyme inhibition assay": 73.3744889835985, "CYP450 metabolism assay": "Strong inhibitor", "Skin sensitization test": "Sensitizer", "Pharmacogenomics analysis": "No genetic impact", "Cytokine release assay": "High cytokine release", "QT prolongation assessment": "No effect on QT"}, "seed": 49, "valid_truth": "Erythromycin"}
